Spots Global Cancer Trial Database for Immunogenicity of Fractional Dose of the HPV Vaccines
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Immunogenicity of Fractional Dose of the HPV Vaccines
Official Title: Immunogenicity of Fractional Dose of the HPV Vaccines
Study ID: NCT05291871
Interventions
Study Description
Brief Summary: This randomized phase IV trial compares intramuscular and intradermal fractional dose of bivalent HPV vaccine to fractional dose of nonavalent HPV vaccine among men and women aged 27-45 years in Seattle, Washington. Participants will have immune response assessed at baseline, 4 weeks, 6 months, and 12 months
Detailed Description:
Keywords
Eligibility
Minimum Age: 27 Years
Eligible Ages: ADULT
Sex: ALL
Healthy Volunteers: Yes
Locations
University of Washington Virology Research Clinic, Seattle, Washington, United States
Contact Details
Name: Helen Stankiewicz Karita, MD
Affiliation: University of Washington
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
